25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

OCLG (Oncologix Tech Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Oncologix Tech Inc together

I guess you are interested in Oncologix Tech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Oncologix Tech Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Oncologix Tech Inc’s Price Targets

I'm going to help you getting a better view of Oncologix Tech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Oncologix Tech Inc

I send you an email if I find something interesting about Oncologix Tech Inc.

1. Quick Overview

1.1. Quick analysis of Oncologix Tech Inc (30 sec.)










1.2. What can you expect buying and holding a share of Oncologix Tech Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$-0.01
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-0.01
Return On Investment
-5,652.7%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Oncologix Tech Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$0.00 - $0.01
Total Value Per Share
$0.00 - $0.01

2.2. Growth of Oncologix Tech Inc (5 min.)




Is Oncologix Tech Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$5.9m-$3.6m-$2.3m-39.4%

How much money is Oncologix Tech Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.3m-$1.8m-$521.1k-22.0%
Net Profit Margin-83.2%-46.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Oncologix Tech Inc (5 min.)




2.4. Comparing to competitors in the Shell Companies industry (5 min.)




  Industry Rankings (Shell Companies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Oncologix Tech Inc?

Welcome investor! Oncologix Tech Inc's management wants to use your money to grow the business. In return you get a share of Oncologix Tech Inc.

First you should know what it really means to hold a share of Oncologix Tech Inc. And how you can make/lose money.

Speculation

The Price per Share of Oncologix Tech Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oncologix Tech Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oncologix Tech Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oncologix Tech Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-1,425.9%0.00-1,425.9%0.00-1,112.5%0.00-1,358.0%0.00-1,051.3%0.00-1,032.7%
Usd Book Value Change Per Share0.00-1,413.2%0.00-1,413.2%0.00-1,082.0%0.00-1,063.8%0.00-647.6%0.00-237.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-1,413.2%0.00-1,413.2%0.00-1,082.0%0.00-1,063.8%0.00-647.6%0.00-237.3%
Usd Price Per Share0.00-0.00-0.00-0.00-0.00-0.02-
Price to Earnings Ratio-0.21--0.21--0.09--0.30--7.24--86.71-
Price-to-Total Gains Ratio-0.21--0.21--0.09--0.53-9.11--179.08-
Price to Book Ratio-0.08--0.08--0.05--0.32--13.24--48.50-
Price-to-Total Gains Ratio-0.21--0.21--0.09--0.53-9.11--179.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10000000 shares)-14,131.67-6,475.70
Gains per Year (10000000 shares)-56,526.69-25,902.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-56527-565370-25903-25913
20-113053-1130640-51806-51816
30-169580-1695910-77708-77719
40-226107-2261180-103611-103622
50-282633-2826450-129514-129525
60-339160-3391720-155417-155428
70-395687-3956990-181320-181331
80-452213-4522260-207223-207234
90-508740-5087530-233125-233137
100-565267-5652800-259028-259040

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.022.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%6.016.00.027.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%1.00.021.04.5%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%7.015.00.031.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Oncologix Tech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%-0.001-23%-0.001-25%-0.001-54%0.000-83%
Book Value Per Share---0.004-0.0040%-0.002-39%-0.002-36%-0.001-58%-0.001-69%
Current Ratio--0.0340.0340%0.160-79%0.152-78%0.142-76%0.087-62%
Debt To Asset Ratio--4.9934.9930%2.682+86%3.085+62%2.349+113%27.784-82%
Debt To Equity Ratio----0%-0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---6935803.995-6935803.9950%-5547545.998-20%-5305643.326-24%1408200.458-593%36155108.876-119%
Eps---0.001-0.0010%-0.001-22%-0.001-5%-0.001-26%-0.001-28%
Ev To Ebitda Ratio--6.2466.2460%4.889+28%4.952+26%-6.358+202%-134.023+2246%
Ev To Sales Ratio---2.433-2.4330%-1.383-43%-1.506-38%12.398-120%12.398-120%
Free Cash Flow Per Share--0.0000.0000%0.000-107%0.000-47%0.000+317%0.000+886%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000-183%0.000-115%0.000-115%0.000-135%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.009----------
Intrinsic Value_10Y_min---0.001----------
Intrinsic Value_1Y_max--0.000----------
Intrinsic Value_1Y_min--0.000----------
Intrinsic Value_3Y_max--0.001----------
Intrinsic Value_3Y_min--0.000----------
Intrinsic Value_5Y_max--0.003----------
Intrinsic Value_5Y_min--0.000----------
Market Cap166247.002-200%498741.005498741.0050%166247.002+200%720403.674-31%6051390.858-92%39117919.476-99%
Net Profit Margin---0.832-0.8320%-0.461-45%-0.604-27%-0.969+17%-0.485-42%
Operating Margin---0.395-0.3950%-0.287-27%-0.291-26%-0.590+49%-0.295-25%
Operating Ratio--1.3031.3030%1.128+16%1.178+11%1.373-5%0.686+90%
Pb Ratio-0.028+67%-0.084-0.0840%-0.046-45%-0.317+279%-13.238+15746%-48.497+57953%
Pe Ratio-0.070+67%-0.210-0.2100%-0.090-57%-0.295+40%-7.244+3343%-86.711+41115%
Price Per Share0.000-200%0.0000.0000%0.000+200%0.000-31%0.004-92%0.024-99%
Price To Free Cash Flow Ratio-6.619+67%-19.857-19.8570%0.482-4220%-7.844-60%16.769-218%-180.117+807%
Price To Total Gains Ratio-0.071+67%-0.212-0.2120%-0.092-56%-0.532+151%9.107-102%-179.077+84255%
Quick Ratio--0.0320.0320%0.152-79%0.141-77%0.122-74%0.068-53%
Return On Assets---1.586-1.5860%-0.859-46%-1.086-31%-0.839-47%-24.335+1435%
Return On Equity----0%-0%-0%-0%-0%
Total Gains Per Share---0.001-0.0010%-0.001-23%-0.001-25%-0.001-54%0.000-83%
Usd Book Value---5970233.000-5970233.0000%-3620885.000-39%-3804402.000-36%-2487733.800-58%-1858295.700-69%
Usd Book Value Change Per Share---0.001-0.0010%-0.001-23%-0.001-25%-0.001-54%0.000-83%
Usd Book Value Per Share---0.004-0.0040%-0.002-39%-0.002-36%-0.001-58%-0.001-69%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---6935803.995-6935803.9950%-5547545.998-20%-5305643.326-24%1408200.458-593%36155108.876-119%
Usd Eps---0.001-0.0010%-0.001-22%-0.001-5%-0.001-26%-0.001-28%
Usd Free Cash Flow---25117.000-25117.0000%344918.000-107%-13335.667-47%-104746.000+317%-247736.700+886%
Usd Free Cash Flow Per Share--0.0000.0000%0.000-107%0.000-47%0.000+317%0.000+886%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000-183%0.000-115%0.000-115%0.000-135%
Usd Market Cap166247.002-200%498741.005498741.0050%166247.002+200%720403.674-31%6051390.858-92%39117919.476-99%
Usd Price Per Share0.000-200%0.0000.0000%0.000+200%0.000-31%0.004-92%0.024-99%
Usd Profit---2370598.000-2370598.0000%-1849451.000-22%-2257667.333-5%-1747698.000-26%-1716878.400-28%
Usd Revenue--2850177.0002850177.0000%4011826.000-29%3921454.667-27%3137217.000-9%1568608.500+82%
Usd Total Gains Per Share---0.001-0.0010%-0.001-23%-0.001-25%-0.001-54%0.000-83%
 EOD+2 -6MRQTTM+0 -0YOY+7 -283Y+4 -315Y+9 -2610Y+9 -26

3.3 Fundamental Score

Let's check the fundamental score of Oncologix Tech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.070
Price to Book Ratio (EOD)Between0-1-0.028
Net Profit Margin (MRQ)Greater than0-0.832
Operating Margin (MRQ)Greater than0-0.395
Quick Ratio (MRQ)Greater than10.032
Current Ratio (MRQ)Greater than10.034
Debt to Asset Ratio (MRQ)Less than14.993
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.586
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Oncologix Tech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Oncologix Tech Inc

Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilities, assisted living facilities, hospitals and medical institutions, federal agencies, home medical care industry, respiratory and therapy- physical/occupational therapy centers. In addition, it distributes and sells home medical equipment for sleep and respiratory therapies; supplies and services durable medical equipment to treat obstructive Sleep Apnea; C-PAP and BiPAP oxygen equipment, a large selection of mask interfaces; and offers personalized treatment plans, as well as monitoring and support services. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.

Fundamental data was last updated by Penke on 2025-04-25 15:26:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Oncologix Tech Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Oncologix Tech Inc to theΒ Shell Companies industry mean.
  • A Net Profit Margin of -83.2%Β means thatΒ $-0.83 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oncologix Tech Inc:

  • The MRQ is -83.2%. The company is making a huge loss. -2
  • The TTM is -83.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-83.2%TTM-83.2%0.0%
TTM-83.2%YOY-46.1%-37.1%
TTM-83.2%5Y-96.9%+13.7%
5Y-96.9%10Y-48.5%-48.5%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-83.2%-94.4%+11.2%
TTM-83.2%-47.9%-35.3%
YOY-46.1%-19.4%-26.7%
3Y-60.4%-2.4%-58.0%
5Y-96.9%-1.7%-95.2%
10Y-48.5%-28.6%-19.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Oncologix Tech Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Oncologix Tech Inc to theΒ Shell Companies industry mean.
  • -158.6% Return on Assets means thatΒ Oncologix Tech Inc generatedΒ $-1.59 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oncologix Tech Inc:

  • The MRQ is -158.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -158.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-158.6%TTM-158.6%0.0%
TTM-158.6%YOY-85.9%-72.7%
TTM-158.6%5Y-83.9%-74.7%
5Y-83.9%10Y-2,433.5%+2,349.6%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-158.6%-4.1%-154.5%
TTM-158.6%-5.4%-153.2%
YOY-85.9%-0.6%-85.3%
3Y-108.6%-1.6%-107.0%
5Y-83.9%-4.3%-79.6%
10Y-2,433.5%-5.4%-2,428.1%
4.3.1.3. Return on Equity

Shows how efficient Oncologix Tech Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Oncologix Tech Inc to theΒ Shell Companies industry mean.
  • 0.0% Return on Equity means Oncologix Tech Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oncologix Tech Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.4%+1.4%
TTM--1.5%+1.5%
YOY-0.8%-0.8%
3Y--0.6%+0.6%
5Y--2.4%+2.4%
10Y--2.4%+2.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Oncologix Tech Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Oncologix Tech Inc is operatingΒ .

  • Measures how much profit Oncologix Tech Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Oncologix Tech Inc to theΒ Shell Companies industry mean.
  • An Operating Margin of -39.5%Β means the company generated $-0.39 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oncologix Tech Inc:

  • The MRQ is -39.5%. The company is operating very inefficient. -2
  • The TTM is -39.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-39.5%TTM-39.5%0.0%
TTM-39.5%YOY-28.7%-10.8%
TTM-39.5%5Y-59.0%+19.5%
5Y-59.0%10Y-29.5%-29.5%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.5%-339.2%+299.7%
TTM-39.5%-53.8%+14.3%
YOY-28.7%-37.9%+9.2%
3Y-29.1%-12.3%-16.8%
5Y-59.0%-13.4%-45.6%
10Y-29.5%-41.1%+11.6%
4.3.2.2. Operating Ratio

Measures how efficient Oncologix Tech Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Shell Companies industry mean).
  • An Operation Ratio of 1.30 means that the operating costs are $1.30 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Oncologix Tech Inc:

  • The MRQ is 1.303. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.303. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.303TTM1.3030.000
TTM1.303YOY1.128+0.176
TTM1.3035Y1.373-0.069
5Y1.37310Y0.686+0.686
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3032.299-0.996
TTM1.3031.391-0.088
YOY1.1281.122+0.006
3Y1.1780.644+0.534
5Y1.3730.483+0.890
10Y0.6860.822-0.136
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Oncologix Tech Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Oncologix Tech Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Shell Companies industry mean).
  • A Current Ratio of 0.03Β means the company has $0.03 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Oncologix Tech Inc:

  • The MRQ is 0.034. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.034. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.034TTM0.0340.000
TTM0.034YOY0.160-0.126
TTM0.0345Y0.142-0.108
5Y0.14210Y0.087+0.054
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0340.068-0.034
TTM0.0340.093-0.059
YOY0.1600.418-0.258
3Y0.1521.224-1.072
5Y0.1421.486-1.344
10Y0.0871.486-1.399
4.4.3.2. Quick Ratio

Measures if Oncologix Tech Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Oncologix Tech Inc to theΒ Shell Companies industry mean.
  • A Quick Ratio of 0.03Β means the company can pay off $0.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oncologix Tech Inc:

  • The MRQ is 0.032. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.032. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.032TTM0.0320.000
TTM0.032YOY0.152-0.120
TTM0.0325Y0.122-0.090
5Y0.12210Y0.068+0.054
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0320.077-0.045
TTM0.0320.303-0.271
YOY0.1520.547-0.395
3Y0.1411.484-1.343
5Y0.1222.399-2.277
10Y0.0682.196-2.128
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Oncologix Tech Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Oncologix Tech IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Oncologix Tech Inc to Shell Companies industry mean.
  • A Debt to Asset Ratio of 4.99Β means that Oncologix Tech Inc assets areΒ financed with 499.3% credit (debt) and the remaining percentage (100% - 499.3%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Oncologix Tech Inc:

  • The MRQ is 4.993. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 4.993. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.993TTM4.9930.000
TTM4.993YOY2.682+2.311
TTM4.9935Y2.349+2.644
5Y2.34910Y27.784-25.435
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9930.719+4.274
TTM4.9930.566+4.427
YOY2.6820.259+2.423
3Y3.0850.409+2.676
5Y2.3490.409+1.940
10Y27.7840.410+27.374
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Oncologix Tech Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Oncologix Tech Inc to theΒ Shell Companies industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oncologix Tech Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.505-0.505
TTM-0.419-0.419
YOY-0.167-0.167
3Y-0.193-0.193
5Y-0.669-0.669
10Y-0.459-0.459
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Oncologix Tech Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Oncologix Tech Inc to theΒ Shell Companies industry mean.
  • A PE ratio of -0.21 means the investor is paying $-0.21Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oncologix Tech Inc:

  • The EOD is -0.070. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.210. Based on the earnings, the company is expensive. -2
  • The TTM is -0.210. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.070MRQ-0.210+0.140
MRQ-0.210TTM-0.2100.000
TTM-0.210YOY-0.090-0.120
TTM-0.2105Y-7.244+7.033
5Y-7.24410Y-86.711+79.467
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.070-8.609+8.539
MRQ-0.210-6.725+6.515
TTM-0.210-6.725+6.515
YOY-0.090-3.704+3.614
3Y-0.295-14.835+14.540
5Y-7.244-25.368+18.124
10Y-86.711-25.368-61.343
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oncologix Tech Inc:

  • The EOD is -6.619. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -19.857. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -19.857. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.619MRQ-19.857+13.238
MRQ-19.857TTM-19.8570.000
TTM-19.857YOY0.482-20.339
TTM-19.8575Y16.769-36.626
5Y16.76910Y-180.117+196.885
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD-6.619-40.951+34.332
MRQ-19.857-43.490+23.633
TTM-19.857-46.065+26.208
YOY0.482-92.603+93.085
3Y-7.844-106.711+98.867
5Y16.769-99.893+116.662
10Y-180.117-98.004-82.113
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Oncologix Tech Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Shell Companies industry mean).
  • A PB ratio of -0.08 means the investor is paying $-0.08Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Oncologix Tech Inc:

  • The EOD is -0.028. Based on the equity, the company is expensive. -2
  • The MRQ is -0.084. Based on the equity, the company is expensive. -2
  • The TTM is -0.084. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.028MRQ-0.084+0.056
MRQ-0.084TTM-0.0840.000
TTM-0.084YOY-0.046-0.038
TTM-0.0845Y-13.238+13.154
5Y-13.23810Y-48.497+35.259
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0281.062-1.090
MRQ-0.0841.432-1.516
TTM-0.0841.110-1.194
YOY-0.0461.314-1.360
3Y-0.3171.454-1.771
5Y-13.2381.454-14.692
10Y-48.4971.491-49.988
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2022-08-31. All numbers in thousands.

Summary
Total Assets-
Total Liabilities-
Total Stockholder Equity1,662
 As reported
Total Liabilities -
Total Stockholder Equity+ 1,662
Total Assets = -

Assets

Total Current Assets
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities-
Long-term Liabilities-
Total Stockholder Equity1,662
Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock1,662
Retained Earnings -49,396
Other Stockholders Equity 49,396
Total Stockholder Equity (as reported)1,662
Total Stockholder Equity (calculated)1,662
+/- 0
Other
Common Stock Shares Outstanding 1,662,469



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2022-08-312021-08-312020-08-312019-08-312017-08-312016-08-312015-08-312014-08-312013-08-312012-08-312011-08-312010-08-312009-08-312008-08-312007-08-312006-08-312005-08-312004-08-312003-08-312002-08-312001-08-312000-08-311999-08-311998-08-311997-08-311996-08-31
> Total Assets 
4,580
3,141
2,542
1,574
13,863
11,265
9,500
5,719
924
459
669
613
240
21
19
15
6
2,034
2,135
3,133
2,153
1,495
0
0
0
0
00001,4952,1533,1332,1352,03461519212406136694599245,7199,50011,26513,8631,5742,5423,1414,580
   > Total Current Assets 
1,381
199
2,227
898
2,605
362
519
350
522
170
462
374
92
11
17
15
5
218
275
1,203
873
250
0
0
0
0
00002508731,2032752185151711923744621705223505193622,6058982,2271991,381
       Cash And Cash Equivalents 
857
13
2,203
890
2,581
286
352
227
405
87
365
142
10
1
11
11
2
39
18
25
60
31
0
0
0
0
0000316025183921111110142365874052273522862,5818902,20313857
       Short-term Investments 
0
0
0
0
0
21
23
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000232100000
       Net Receivables 
281
176
18
0
0
19
73
74
78
63
72
0
0
0
0
0
0
108
213
1,062
770
210
0
0
0
0
00002107701,0622131080000007263787473190018176281
       Inventory 
241
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
31
105
31
3
0
0
0
0
000033110531310000000000000000241
       Other Current Assets 
2
10
7
9
24
37
72
49
38
21
25
232
82
10
6
4
3
78
12
11
11
7
0
0
0
0
000071111127834610822322521384972372497102
   > Long-term Assets 
3,199
2,941
315
676
11,257
10,903
8,981
5,369
402
288
207
239
148
11
2
0
1
1,816
1,861
1,930
1,281
1,245
0
0
0
0
00001,2451,2811,9301,8611,816102111482392072884025,3698,98110,90311,2576763152,9413,199
       Property Plant Equipment 
540
410
259
364
1,208
2,356
1,625
910
351
208
115
203
5
3
2
0
1
79
40
34
24
14
0
0
0
0
00001424344079102352031152083519101,6252,3561,208364259410540
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,696
1,782
1,813
1,191
1,191
0
0
0
0
00001,1911,1911,8131,7821,69600000000000000000
       Intangible Assets 
8
29
0
0
8,509
7,127
5,745
4,362
0
0
0
0
0
0
0
0
0
31
24
1,832
1,203
1,197
0
0
0
0
00001,1971,2031,83224310000000004,3625,7457,1278,50900298
       Long-term Assets Other 
336
2,502
30
122
1,541
1,420
1,611
97
51
80
92
36
144
5
0
0
0
10
15
-1,749
-1,136
-1,156
0
0
0
0
0000-1,156-1,136-1,7491510000514436928051971,6111,4201,541122302,502336
> Total Liabilities 
1,071
983
389
281
211
164
1,046
909
456
199
1,271
2,638
2,736
1,839
615
662
594
2,395
2,800
4,955
5,774
7,465
6,666
6,666
6,666
0
06,6666,6666,6667,4655,7744,9552,8002,3955946626151,8392,7362,6381,2711994569091,0461642112813899831,071
   > Total Current Liabilities 
715
779
364
280
211
164
1,046
902
453
199
1,271
1,950
1,925
1,476
253
662
234
1,583
2,405
4,560
5,459
7,465
6,666
6,666
6,666
0
06,6666,6666,6667,4655,4594,5602,4051,5832346622531,4761,9251,9501,2711994539021,046164211280364779715
       Short-term Debt 
85
200
109
37
2
0
203
595
202
84
902
1,731
1,437
1,108
75
150
360
263
1,517
3,015
4,133
5,155
3,044
3,044
3,044
0
03,0443,0443,0445,1554,1333,0151,517263360150751,1081,4371,73190284202595203023710920085
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
360
360
360
485
3,015
4,133
5,155
0
0
0
0
00005,1554,1333,015485360360360000000000000000
       Accounts payable 
0
400
0
0
209
154
700
291
240
100
247
46
269
264
131
140
143
896
733
943
788
1,202
0
0
0
0
00001,20278894373389614314013126426946247100240291700154209004000
       Other Current Liabilities 
631
200
255
243
209
10
129
16
12
16
112
173
220
105
46
373
91
424
155
601
1,051
1,108
3,623
3,623
3,623
0
03,6233,6233,6231,1081,051601155424913734610522017311216121612910209243255200631
   > Long-term Liabilities 
355
204
25
2
0
0
0
7
3
0
0
688
811
363
363
0
360
812
396
395
315
0
0
0
0
0
0000031539539681236003633638116880037000225204355
> Total Stockholder Equity
3,510
2,158
2,153
1,293
13,652
11,101
8,454
4,810
468
260
-602
-2,025
-2,496
-1,814
-593
-644
-584
-357
-665
-1,822
-3,621
-5,970
-6,666
-6,666
-6,666
1,662
1,662-6,666-6,666-6,666-5,970-3,621-1,822-665-357-584-644-593-1,814-2,496-2,025-6022604684,8108,45411,10113,6521,2932,1532,1583,510
   Common Stock
14
15
17
3
3
12
17
30
42
47
60
71
114
156
189
51
58
75
135
476
737
737
1,513
1,513
1,513
1,662
1,6621,5131,5131,5137377374761357558511891561147160474230171233171514
   Retained Earnings -49,396-55,880-55,880-55,880-55,143-52,773-50,923-48,370-58,992-58,339-58,053-57,818-57,075-54,499-49,909-42,262-36,176-35,402-28,585-23,489-17,021-13,006-7,468-6,381-4,882-3,252
   Capital Surplus 00000000000000000000000000
   Treasury Stock0000000000000000-912-912-9120000000
   Other Stockholders Equity 
6,748
7,043
8,517
8,758
26,655
28,110
31,042
33,362
35,826
36,389
41,600
47,805
51,890
55,104
57,177
57,359
116,036
58,560
47,571
48,569
49,152
48,425
49,246
49,246
49,246
49,396
49,39649,24649,24649,24648,42549,15248,56947,57158,560116,03657,35957,17755,10451,89047,80541,60036,38935,82633,36231,04228,11026,6558,7588,5177,0436,748



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2022-08-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = 0
0
0
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-0
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Oncologix Tech Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oncologix Tech Inc. The general trend of Oncologix Tech Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oncologix Tech Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Oncologix Tech Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oncologix Tech Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Know someone who trades $OCLG? Share this with them.πŸ‘‡

Oncologix Tech Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oncologix Tech Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oncologix Tech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oncologix Tech Inc. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oncologix Tech Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Oncologix Tech Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Oncologix Tech Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Oncologix Tech Inc Daily Moving Average Convergence/Divergence (MACD) ChartOncologix Tech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oncologix Tech Inc. The current adx is 88.18.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Oncologix Tech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oncologix Tech Inc. The current sar is 0.00010096.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Oncologix Tech Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oncologix Tech Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Oncologix Tech Inc Daily Relative Strength Index (RSI) ChartOncologix Tech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oncologix Tech Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oncologix Tech Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Oncologix Tech Inc Daily Stochastic Oscillator ChartOncologix Tech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oncologix Tech Inc. The current cci is -66.66666667.

Oncologix Tech Inc Daily Commodity Channel Index (CCI) ChartOncologix Tech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oncologix Tech Inc. The current cmo is 0.

Oncologix Tech Inc Daily Chande Momentum Oscillator (CMO) ChartOncologix Tech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oncologix Tech Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Oncologix Tech Inc Daily Williams %R ChartOncologix Tech Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Oncologix Tech Inc.

Oncologix Tech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oncologix Tech Inc. The current atr is 0.

Oncologix Tech Inc Daily Average True Range (ATR) ChartOncologix Tech Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oncologix Tech Inc. The current obv is 62,989,396.

Oncologix Tech Inc Daily On-Balance Volume (OBV) ChartOncologix Tech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oncologix Tech Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Oncologix Tech Inc Daily Money Flow Index (MFI) ChartOncologix Tech Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oncologix Tech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Oncologix Tech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oncologix Tech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Oncologix Tech Inc with someone you think should read this too:
  • Are you bullish or bearish on Oncologix Tech Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oncologix Tech Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oncologix Tech Inc

I send you an email if I find something interesting about Oncologix Tech Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Oncologix Tech Inc.

Receive notifications about Oncologix Tech Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.